Shares of InfuSystem Holdings, Inc. (NYSE:INFU – Get Free Report) have received a consensus rating of “Buy” from the five research firms that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold rating, two have assigned a buy rating and two have given a strong buy rating to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $15.00.
Separately, Roth Mkm reissued a “buy” rating and issued a $15.00 target price (up from $14.00) on shares of InfuSystem in a report on Tuesday.
Read Our Latest Research Report on INFU
Institutional Trading of InfuSystem
InfuSystem Price Performance
NYSE INFU opened at $8.77 on Tuesday. The business’s fifty day moving average is $8.41 and its 200 day moving average is $9.32. InfuSystem has a fifty-two week low of $4.61 and a fifty-two week high of $11.04. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.59 and a current ratio of 1.98. The company has a market capitalization of $178.35 million, a PE ratio of 146.19 and a beta of 1.67.
InfuSystem Company Profile
InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.
In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.
Featured Articles
- Five stocks we like better than InfuSystem
- The gold chart Wall Street is terrified of…
- This makes me furious
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.
